Director Scott M. Sperling filed a Form 4 with the SEC on October 30, 2026, reporting a disposition of 3,490 shares of Thermo Fisher Scientific Inc. common stock on October 28, 2026, via a gift transaction coded "G" at a price of $0.

Key Highlights

  • Reporting person: Scott M. Sperling, identified as a Director of Thermo Fisher Scientific Inc. (NYSE:TMO).
  • Transaction type: 3,490 shares of common stock disposed of (code "G," a gift) on October 28, 2026, at a price of $0.
  • Remaining direct ownership: Following the transaction, Sperling directly beneficially owns 65,989 shares of common stock.
  • No derivative securities: Table II of the filing contains no reportable derivative security transactions.
  • Filing signed: The form was signed by Melodie T. Morin as Attorney-in-Fact for Scott M. Sperling on October 30, 2026.

Sperling's October 2026 Gift Transaction in Thermo Fisher Scientific Common Stock

According to the Form 4 filed with the SEC, Scott M. Sperling, a director of Thermo Fisher Scientific Inc. (NYSE:TMO) whose address is listed as c/o Thomas H. Lee Partners, L.P., 100 Federal Street, 36th Floor, Boston, Massachusetts 02110, reported a change in his beneficial ownership of company common stock. The filing covers a transaction dated October 28, 2026, with the Form 4 itself filed on October 30, 2026.

The filing discloses a single non-derivative transaction in Table I: 3,490 shares of Thermo Fisher Scientific common stock were disposed of under transaction code "G," indicating a gift, at a stated price of $0. The shares are recorded as directly owned and disposed of (D). No deemed execution date is noted. Following this reported transaction, Sperling's direct beneficial ownership stands at 65,989 shares of common stock, according to the filing.

Table II, covering derivative securities such as options, warrants, or convertible securities, contains no reported transactions. The filing was made by one reporting person and is not identified as an amendment to a prior form. It was executed by Melodie T. Morin as Attorney-in-Fact for Scott M. Sperling.

What Was Disclosed

The filing discloses a gift of 3,490 shares of Thermo Fisher Scientific common stock by director Scott M. Sperling on October 28, 2026, at $0, leaving him with 65,989 directly held shares following the transaction.